.
MergerLinks Header Logo

New Deal


Announced

Artemis Capital Partners to acquire BioDot.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Private Equity

Acquisition

Private

Pending

Majority

Friendly

Life Science Equipment

United States

Single Bidder

Medical Equipment

Synopsis

Edit

Artemis Capital Partners, a Boston-based private equity firm, agreed to acquire BioDot, a manufacturer of low volume precision and dispensing equipment. Financial terms were not disclosed. "This is an exciting time for our Company and we are thrilled to partner with Artemis. With the combined innovation of BioDot and the strategic ownership of Artemis, we will make a profound difference for our customers by continuing to deliver new high-demand technology-driven solutions globally with the quality and service that they can continue to rely upon," Anthony Lemmo, BioDot Chief Executive Officer.

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US